These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Etretinate, lomustine, and bleomycin versus lomustine and bleomycin in advanced squamous cell lung carcinoma. Weber W; Obrecht JP Cancer Treat Rep; 1983 Sep; 67(9):847-9. PubMed ID: 6192913 [No Abstract] [Full Text] [Related]
27. Phase II study of CCNU (NSC-79037) in the treatment of advanced gastrointestinal cancer. Klaassen DJ; Rapp E Cancer Chemother Rep; 1974; 58(5 Pt 1):667-9. PubMed ID: 4426046 [No Abstract] [Full Text] [Related]
28. Combination of lomustine and cimetidine in the treatment of a patient with malignant glioblastoma: a case report. Hess WA; Kornblith PL Cancer Treat Rep; 1985 Jun; 69(6):733. PubMed ID: 4016781 [No Abstract] [Full Text] [Related]
29. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU. Young RC; DeVita VT; Serpick AA; Canellos GP N Engl J Med; 1971 Aug; 285(9):475-9. PubMed ID: 5558887 [No Abstract] [Full Text] [Related]
30. Combination cytotoxic chemotherapy with CCNU, procarbazine, and vincristine in disseminated cutaneous malignant melanoma: 3 years, followup. Carmo-Pereira J; Costa FO; Pimentel P; Henriques E Cancer Treat Rep; 1980 Jan; 64(1):143-5. PubMed ID: 7379048 [TBL] [Abstract][Full Text] [Related]
31. Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea. Woolley PV; Luc PV; Rahman A; Korsmeyer SJ; Smith FP; Schein PS Cancer Res; 1981 Oct; 41(10):3896-900. PubMed ID: 7284999 [TBL] [Abstract][Full Text] [Related]
32. CCNU (lomustine) toxicity in dogs: a retrospective study (2002-07). Heading KL; Brockley LK; Bennett PF Aust Vet J; 2011 Apr; 89(4):109-16. PubMed ID: 21418164 [TBL] [Abstract][Full Text] [Related]
33. Lomustine (CeeNU). Med Lett Drugs Ther; 1976 Nov; 18(24):102-3. PubMed ID: 995062 [No Abstract] [Full Text] [Related]
34. [Phase I study of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). Phase I Study Group]. Gan To Kagaku Ryoho; 1986 Jul; 13(7):2425-33. PubMed ID: 3729497 [TBL] [Abstract][Full Text] [Related]
35. Phase I trial of PCNU. Kalman LA; Gralla RJ; Casper ES; Kris MG; Gordon C; Woodcock TM Cancer Treat Rep; 1983 Nov; 67(11):1027-9. PubMed ID: 6315229 [TBL] [Abstract][Full Text] [Related]
36. BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea; NSC-409962) in the treatment of malignant brain tumor--a preliminary report. Walker MD; Hurwitz BS Cancer Chemother Rep; 1970 Aug; 54(4):263-71. PubMed ID: 4946011 [No Abstract] [Full Text] [Related]
37. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4]. Brunner KW; Maurice P; Sonntag RW Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016 [No Abstract] [Full Text] [Related]
38. Logistic regression model of fotemustine toxicity combining independent phase II studies. Raymond E; Haon C; Boaziz C; Coste M Cancer; 1996 Nov; 78(9):1980-7. PubMed ID: 8909320 [TBL] [Abstract][Full Text] [Related]
39. Preliminary report on the use of CCNU (NSC-79037), adriamycin (NSC-123127), and hexamethylmelamine (NSC-13875) in carcinoma of the lung. Wilson WL; Andrews NC; Frelick RW; Nealon TF; Bick RL; Adams T Cancer Treat Rep; 1976 Mar; 60(3):269-71. PubMed ID: 816467 [No Abstract] [Full Text] [Related]